Patents
Sitemap › C12 - Biochemistry; Beer; Spirits; Wine; Vinegar; Microbiology; Enzymology; Mutation or genetic engineering › C12P - Fermentation or enzyme-using processes to synthesise a desired chemical compound or composition or to separate optical isomers from a racemic mixture › C12P 21 - Preparation of peptides or proteins
Patents for C12P 21 - Preparation of peptides or proteins (112,499)
09/2012
09/19/2012CN102676625A Preparation method of bioactive peptide capable of inhabiting neuraminidase
09/19/2012CN102676624A Method for producing active peptide from peanut cake and meal by immobilized enzyme
09/19/2012CN102676623A Method for preparing antioxidant peptide from shrimp shell
09/19/2012CN102676622A Andrias davidianus nano peptide and andrias davidianus wine
09/19/2012CN102676621A Antihypertensive rapeseed peptide and preparation method and application of antihypertensive rapeseed peptide
09/19/2012CN102676620A Preparation method of high-molecular-weight squid skin collagen
09/19/2012CN102676619A Comprehensive utilization process for marine fish skins
09/19/2012CN102676570A Recombinant bacillus subtilis immunoglobulin binding protein functional-domain expression vector and application thereof
09/19/2012CN102675437A Method for adjusting size of plant organs and inside asymmetry of floral organs
09/19/2012CN102675431A Antitumor antibiotic gaddie mycin generated by streptosporangium C-3560
09/19/2012CN102675411A Method for preparing biotoxin
09/19/2012CN102671181A High purity lipopeptides, lipopeptide micelles and processes for preparing same
09/19/2012CN102010884B Antibacterial active matter as well as preparation method and application thereof
09/19/2012CN101624568B Nanometer molecular biosensor, preparation method and application thereof
09/18/2012US8268979 Human MutY
09/18/2012US8268976 Flea GABA receptor subunit nucleic acid molecules
09/18/2012US8268973 Anti-amyloid antibodies
09/18/2012US8268971 Antibody therapy for modulating function of intestinal receptors and methods of treating diabetes and obesity
09/18/2012US8268970 Human antibodies that bind mesothelin, and uses thereof
09/18/2012US8268886 Pyrenyloxysulfonic acid fluorescent agents
09/18/2012US8268756 Mixture of binding proteins
09/18/2012US8268618 Repressing endogenous CCR5 gene expression in cells using engineered zinc finger proteins
09/18/2012US8268617 Anti-IGF-I receptor antibodies, DNAs, vectors, host cells and genetic constructs
09/18/2012US8268615 Expression, purification and uses of a plasmodium falciparum liver stage antigen 1 polypeptide
09/18/2012US8268606 Polypeptides having endoglucanase activity and polynucleotides encoding same
09/18/2012US8268594 pyrC as a selection marker in Escherichia coli
09/18/2012US8268593 Polynucleotides encoding antibodies directed against amyloid-beta peptide
09/18/2012US8268592 Anti-system ASC amino acid transporter 2 (ASCT2) antibody
09/18/2012US8268590 Non-activated polypeptides having a function of tissue regeneration and method for preparing the same
09/18/2012US8268589 Polypeptides having endoglucanase activity and polynucleotides encoding same
09/18/2012US8268587 Immunosuppressive polypeptides and nucleic acids
09/18/2012US8268586 Modified messenger RNA stabilizing sequences for expressing genes in bacterial cells
09/18/2012US8268585 Chrysosporium mutants for use as bioreactor in production/fermentation of heterologous polypeptides
09/18/2012US8268584 Hydrogen production from microbial strains
09/18/2012US8268583 Cell with improved secretion mediated by MrgA protein or homologue
09/18/2012US8268582 Methods of synthesizing heteromultimeric polypeptides in yeast using a haploid mating strategy
09/18/2012US8268581 Carboxy terminal residues as predictors and regulators of protein stability
09/18/2012US8268578 Method of bioassaying yokukansan
09/18/2012US8268329 Modified Vaccinia ankara virus variant
09/18/2012US8268326 Compositions comprising HMW-MAA and fragments thereof, and methods of use thereof
09/18/2012US8268325 Modified Vaccinia Ankara virus variant
09/18/2012US8268324 Modified galectin 9 proteins and use thereof
09/18/2012US8268319 Immunoconjugates with an intracellularly-cleavable linkage
09/18/2012US8268308 Means for the diagnosis and therapy of CTCL
09/18/2012CA2603414C Anti-cd20 monoclonal antibody
09/18/2012CA2474146C A method for evolving a cell having desired phenotype and evolved cells
09/18/2012CA2454750C Immunologically significant herpes simplex virus antigens and methods for using same
09/18/2012CA2424602C Antibody composition-producing cell
09/18/2012CA2395587C Method of monomerizing human serum albumin polymers
09/18/2012CA2369812C Mink-related genes, formation of potassium channels and association with cardiac arrhythmia
09/18/2012CA2279554C Vascular endothelial growth factor c (vegf-c) protein and gene, mutants thereof, and uses thereof
09/18/2012CA2252972C Serum-free production of recombinant proteins and adenoviral vectors
09/18/2012CA2221293C Helper virus-free aav production
09/13/2012WO2012122444A1 Combination of local and systemic immunomodulative therapies for enhanced treatment of cancer
09/13/2012WO2012121392A1 Azophosphorus compound and azole compound library and method for producing same
09/13/2012WO2012121029A1 Method for accumulating protein in plant cells
09/13/2012WO2012119524A1 Preparation method of new recombinant antibacterial polypeptide medicine
09/13/2012WO2012064162A3 Membrane protein expression vector comprising a fusion partner consisting of the envelope protein p9 of cystovirus phi 12, and a membrane protein production method using the same
09/13/2012US20120233726 Novel bacillus thuringiensis gene with lepidopteran activity
09/13/2012US20120232007 Method for producing proteins in pichia pastoris that lack detectable cross binding activity to antibodies against host cell antigens
09/13/2012US20120232005 Lipoprotein complexes and manufacturing and uses thereof
09/13/2012US20120231506 Multistep final filtration
09/13/2012US20120231505 Gene Expression Technique
09/13/2012US20120231504 Multiuse reactors and related methods
09/13/2012US20120231503 Gene Expression Technique
09/13/2012US20120231502 Method for producing therapeutic proteins in pichia pastoris lacking dipeptidyl aminopeptidase activity
09/13/2012US20120231501 Methods For Increasing Homologous Recombination Of A Nucleic Acid Sequence
09/13/2012US20120231500 Cells For Transient Expression And Uses Thereof
09/13/2012US20120231499 High-molecular-weight recombinant silk or silk-like protein and micro- or nano-sized spider silk or silk-like fiber produced therefrom
09/13/2012US20120231498 Processing enzymes fused to basic protein tags
09/13/2012US20120231497 Selective enzymatic hydrolysis of c-terminal tert-butyl esters of peptides
09/13/2012US20120231496 Composition for synthesizing protein with reduced lipopolysaccharide contamination, method for producing protein using said composition
09/13/2012US20120231474 Constructs that allow for detection and quantitation of membrane proteins
09/13/2012US20120231030 Multi-epitopic vaccine
09/13/2012US20120231029 Enhanced malaria msp-1 subunit vaccine
09/13/2012US20120231019 Fibrosis inhibitor
09/13/2012US20120231006 Anti-orai1 antigen binding proteins and uses thereof
09/13/2012US20120231005 Ax1 and ax189 psck9 antagonists and variants
09/13/2012US20120230995 Polyspecific binding molecules and uses thereof
09/13/2012US20120230992 Vegf-related protein
09/13/2012US20120230990 Humanized antibodies against human il-22ra
09/13/2012US20120230980 OPTIMIZED Fc VARIANTS AND METHODS FOR THEIR GENERATION
09/13/2012US20120230965 Novel Microorganism Bacillus megaterium Toha Producing L-Type Poly-Gamma-Glutamic Acid and L-Type Poly-Gamma-Glutamic Acid Produced Thereby
09/13/2012US20120230947 Biologically active proteins having increased in vivo and/or in vitro stability
09/13/2012US20120230946 Fusion molecules and il-15 variants
09/13/2012US20120230911 Tnf-alpha binding proteins
09/13/2012DE102011005288A1 Producing protein hydrolyzate, useful as angiotensin converting enzyme inhibitor, comprises enzymatically hydrolyzing protein containing substrate in two treatment steps with different proteolytic enzymes
09/13/2012CA2829110A1 Low fucose cell lines and uses thereof
09/13/2012CA2828998A1 Preparation method of new recombinant antibacterial polypeptide medicine
09/13/2012CA2828940A1 Combination of local and systemic immunomodulative therapies for enhanced treatment of cancer
09/13/2012CA2828411A1 Vectors conditionally expressing protein
09/12/2012EP2497833A1 Method for preparing yeast mannose protein product
09/12/2012EP2496707A1 Engineered anti-tslp antibody
09/12/2012EP2496706A1 Methods of generating improved antigen-binding agents using chain shuffling and optionally somatic hypermutation
09/12/2012EP2496597A2 T-cell stimulating protein b and methods of use
09/12/2012EP1360287B1 Methods of modifying eukaryotic cells
09/12/2012CN102666875A Dual variable domain immunoglobulins and uses thereof
09/12/2012CN102666874A Fc region-containing polypeptides that exhibit improved effector function due to alterations of the extent of fucosylation, and methods for their use
09/12/2012CN102666873A Secretory protein biomarkers for high efficiency protein expression
09/12/2012CN102666844A Glycosyl transferase from Chinese hamster and related methods
1 ... 67 68 69 70 71 72 73 74 75 76 77 78 79 80 81 82 83 84 85 86 87 ... 1125